Literature DB >> 9117040

The experience of fatigue and other symptoms in patients receiving chemotherapy.

A Richardson1, E Ream.   

Abstract

Fatigue has been recognized as the most frequently reported symptom of cancer and cancer therapy. There is a lack of research on such aspects as the pattern of fatigue which accompanies treatment, its exacerbating and relieving factors, the different mechanisms of fatigue and its relationship with the factors purported to be related to the fatigue experience. It has been suggested that cancer patients may be those best placed to reveal the likely causes of fatigue. As part of a larger study examining the pattern of fatigue in cancer patients who were undergoing a course of chemotherapy treatment, patients' perceptions of fatigue and tiredness and the nature, pattern and causes of fatigue in relation to cancer and its treatment were obtained. In addition to a diary, interviews were conducted at two time points, at the beginning and end of a cycle of chemotherapy, with over 100 cancer patients. Just under 90% of the sample reported fatigue at some point during a cycle of chemotherapy. The majority of the sample did not consider tiredness and fatigue to constitute the same feelings. Subjects attributed their fatigue to a combination of factors but most frequently mentioned treatment, changes in sleep patterns and other symptoms. Implications for practice and research are outlined.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 9117040     DOI: 10.1111/j.1365-2354.1996.tb00248.x

Source DB:  PubMed          Journal:  Eur J Cancer Care (Engl)        ISSN: 0961-5423            Impact factor:   2.520


  14 in total

1.  Fatigue in the Danish general population. Influence of sociodemographic factors and disease.

Authors:  T Watt; M Groenvold; J B Bjorner; V Noerholm; N A Rasmussen; P Bech
Journal:  J Epidemiol Community Health       Date:  2000-11       Impact factor: 3.710

2.  Ecological momentary assessment of fatigue following breast cancer treatment.

Authors:  Shelly L Curran; Abbie O Beacham; Michael A Andrykowski
Journal:  J Behav Med       Date:  2004-10

3.  Few changes observed in polysomnographic-assessed sleep before and after completion of chemotherapy.

Authors:  Joseph A Roscoe; Michael L Perlis; Wilfred R Pigeon; Kristen H O'Neill; Charles E Heckler; Sara E Matteson-Rusby; Oxana G Palesh; Michelle Shayne; Alissa Huston
Journal:  J Psychosom Res       Date:  2011-09-22       Impact factor: 3.006

4.  Is increasing physical activity necessary to diminish fatigue during cancer treatment? Comparing cognitive behavior therapy and a brief nursing intervention with usual care in a multicenter randomized controlled trial.

Authors:  Martine M Goedendorp; Marlies E W J Peters; Marieke F M Gielissen; J Alfred Witjes; Jan Willem Leer; Constans A H H V M Verhagen; Gijs Bleijenberg
Journal:  Oncologist       Date:  2010-10-07

5.  Relationship of exercise to quality of life in cancer patients beginning chemotherapy.

Authors:  Leigh Anne Faul; Heather S Jim; Susan Minton; Mayer Fishman; Tawee Tanvetyanon; Paul B Jacobsen
Journal:  J Pain Symptom Manage       Date:  2011-02-18       Impact factor: 3.612

6.  Course of fatigue in women receiving chemotherapy and/or radiotherapy for early stage breast cancer.

Authors:  Kristine A Donovan; Paul B Jacobsen; Michael A Andrykowski; Erin M Winters; Lodovico Balducci; Uzma Malik; Daniel Kenady; Patrick McGrath
Journal:  J Pain Symptom Manage       Date:  2004-10       Impact factor: 3.612

7.  Fatigue states after cancer treatment occur both in association with, and independent of, mood disorder: a longitudinal study.

Authors:  David Goldstein; Barbara Bennett; Michael Friedlander; Tracey Davenport; Ian Hickie; Andrew Lloyd
Journal:  BMC Cancer       Date:  2006-10-09       Impact factor: 4.430

Review 8.  Systematic review of sleep disorders in cancer patients: can the prevalence of sleep disorders be ascertained?

Authors:  Julie L Otte; Janet S Carpenter; Shalini Manchanda; Kevin L Rand; Todd C Skaar; Michael Weaver; Yelena Chernyak; Xin Zhong; Christele Igega; Carol Landis
Journal:  Cancer Med       Date:  2014-11-30       Impact factor: 4.452

Review 9.  Benefits of remote real-time side-effect monitoring systems for patients receiving cancer treatment.

Authors:  Sarah Kofoed; Sibilah Breen; Karla Gough; Sanchia Aranda
Journal:  Oncol Rev       Date:  2012-06-05

10.  Potential role of levocarnitine supplementation for the treatment of chemotherapy-induced fatigue in non-anaemic cancer patients.

Authors:  F Graziano; R Bisonni; V Catalano; R Silva; S Rovidati; E Mencarini; B Ferraro; F Canestrari; A M Baldelli; A De Gaetano; P Giordani; E Testa; V Lai
Journal:  Br J Cancer       Date:  2002-06-17       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.